Seer to Report Second Quarter 2023 Financial Results on August 8, 2023
13 Julho 2023 - 5:05PM
Seer, Inc. (Nasdaq: SEER), a leading life sciences company
commercializing a disruptive new platform for proteomics, today
announced that it will report financial results for the second
quarter of 2023 after market close on Tuesday, August 8, 2023.
Company management will be webcasting a conference call beginning
at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Live audio of the webcast will be available on
the Investor section of Seer’s website at investor.seer.bio. An
archived replay will be available on the company’s website
following the event.
About SeerSeer is a life
sciences company developing transformative products that open a new
gateway to the proteome. Seer’s Proteograph™ Product Suite is an
integrated solution that includes proprietary engineered
nanoparticles, consumables, automation instrumentation and software
to perform deep, unbiased proteomic analysis at scale in a matter
of hours. Seer designed the Proteograph workflow to be efficient
and easy to use, leveraging widely adopted laboratory
instrumentation to provide a decentralized solution that can be
incorporated by nearly any lab. Seer’s Proteograph Product Suite is
for research use only and is not intended for diagnostic
procedures. For more information, please visit www.seer.bio.
Investor ContactCarrie
Mendivilinvestor@seer.bio
Media ContactElizabeth
Eatonpr@seer.bio
Seer (NASDAQ:SEER)
Gráfico Histórico do Ativo
De Ago 2024 até Set 2024
Seer (NASDAQ:SEER)
Gráfico Histórico do Ativo
De Set 2023 até Set 2024